4.7 Review

Mesenchymal stem cells: From regeneration to cancer

Journal

PHARMACOLOGY & THERAPEUTICS
Volume 200, Issue -, Pages 42-54

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2019.04.005

Keywords

Mesenchymal stem cells; Regeneration; Cancer; Wound healing; Tumor microenvironment

Funding

  1. National Institutes of Health [R00-CA188093, P30-CA034196, R01-AI132963, UC4-DK104218]
  2. U.S. Department of Defense [BC170584]
  3. Young Scholars Program of Shandong University, China [2015wljh46]

Ask authors/readers for more resources

Mesenchymal stem cells (MSCs) are multipotent tissue stem cells that differentiate into a number of mesodermal tissue types, including osteoblasts, adipocytes, chondrocytes and myofibroblasts. MSCs were originally identified in the bone marrow (BM) of humans and other mammals, but recent studies have shown that they are multilineage progenitors in various adult organs and tissues. MSCs that localize at perivascular sites function to rapidly respond to external stimuli and coordinate with the vascular and immune systems to accomplish the wound healing process. Cancer, considered as wounds that never heal, is also accompanied by changes in MSCs that parallels the wound healing response. MSCs are now recognized as key players at distinct steps of tumorigenesis. In this review, we provide an overview of the function of MSCs in wound healing and cancer progression with the goal of providing insight into the development of novel MSC-manipulating strategies for clinical cancer treatment. (C) 2019 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available